Hisamitsu Pharmaceutical financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Rev. Revenue
¥83.55B ¥102.67B ¥109.79B ¥119.06B ¥124.66B ¥129.83B ¥137.18B ¥137.79B ¥142.77B ¥150.64B ¥156.74B ¥161.85B ¥145.93B ¥147.87B ¥143.41B ¥140.99B ¥114.51B ¥120.19B ¥128.33B ¥141.71B ¥0.00M
GM % Gross Margin %
70.41% 70.93% 70.03% 69.68% 68.00% 67.14% 65.23% 66.05% 63.82% 63.18% 63.59% 63.97% 63.57% 62.34% 61.84% 62.13% 60.41% 58.30% 56.65% 55.73% 0.00%
OM Operating Margin
25.85% 24.37% 23.84% 24.42% 26.10% 22.04% 20.58% 18.75% 17.74% 12.70% 13.10% 17.13% 18.03% 17.82% 15.54% 16.12% 9.32% 7.77% 9.04% 9.29% 0.00%
EPS Earnings Per Share
¥0.00
Div. Dividends
¥16.00 ¥32.00 ¥45.00 ¥60.00 ¥63.00 ¥68.00 ¥70.00 ¥70.00 ¥70.00 ¥75.00 ¥80.00 ¥81.00 ¥81.50 ¥82.00 ¥82.50 ¥83.00 ¥83.50 ¥84.00 ¥84.50 ¥85.00 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
90.78m 90.66m 88.66m 88.68m 88.69m 87.67m 86.67m 85.67m 85.67m 85.67m 85.67m 84.67m 84.51m 83.67m 83.66m 81.36m 81.73m 81.14m 79.74m 76.79m 75.74m
OCF Operating Cash Flow
¥20.13B ¥23.11B ¥12.23B ¥25.72B ¥22.38B ¥20.50B ¥36.34B ¥25.56B ¥32.49B ¥35.85B ¥23.23B ¥30.92B ¥19.91B ¥30.45B ¥15.77B ¥27.40B ¥5.29B ¥19.20B ¥12.73B ¥18.19B ¥0.00M
FCF Free Cash Flow
¥17.95B ¥19.32B ¥6.59B ¥17.36B ¥17.91B ¥13.65B ¥30.40B ¥15.27B ¥27.32B ¥32.00B ¥17.68B ¥26.97B ¥20.98B ¥29.08B ¥-23530.00M ¥23.68B ¥1.72B ¥6.14B ¥1.70B ¥4.92B ¥0.00M
FCFS Free Cash Flow Per Share
¥195.73 ¥201.35 ¥74.85 ¥182.23 ¥184.89 ¥153.85 ¥348.19 ¥114.07 ¥313.42 ¥369.30 ¥217.74 ¥302.63 ¥197.69 ¥324.07 ¥145.07 ¥288.14 ¥23.27 ¥184.77 ¥60.74 ¥66.98 ¥0.00